| Survival: | N/R |
| Toxicity Grade: | 3 |
| Treatments: | Alternative |
| Drugs: | |
| Country: | United States |
| City/State/Province: | Houston, Texas |
| Hospital: | University of Texas, M. D. Anderson Cancer Center |
| Journal: | Link |
| Date: | 3/2001 |
| Description |
| Patients: This Phase I trial involved 49 patients with a variety of different cancers. Three of the 49 patients had mesothelioma. Treatment: The treatment consisted of an extract from green tea (Camellia sinensis). Toxicity: Toxicities included grade 3 constipation, and grade 2 palpitations, fatigue, vomiting, pain, and cough. Results: The median duration of therapy was only two months. There were no major responses and overall survival was not discussed. Support: Ito En, Ltd provided research support. This company markets green tea extract. Correspondence: Katherine M.W. Pisters, MD |